Any feedback?
Literature summary for 3.4.21.22 extracted from
- Sustained release of transgenic human factor IX: Preparation, characterization, and in vivo efficacy (2011), Mol. Pharm., 8, 1767-1774.
Activating Compound
| Activating Compound | Comment | Organism | Structure |
|---|---|---|---|
| Factor VIIIa | - |
Homo sapiens |
Application
| Application | Comment | Organism |
|---|---|---|
| medicine | long-acting FIX microspheres are used in hemophilic prophylaxis | Homo sapiens |
Cloned(Commentary)
| Cloned (Comment) | Organism |
|---|---|
- |
Homo sapiens |
Organism
| Organism | UniProt | Comment | Textmining |
|---|---|---|---|
| Homo sapiens | - |
- |
- |
Source Tissue
| Source Tissue | Comment | Organism | Textmining |
|---|---|---|---|
| blood plasma | - |
Homo sapiens | - |
Synonyms
| Synonyms | Comment | Organism |
|---|---|---|
| factor IX | - |
Homo sapiens |
| FIX | - |
Homo sapiens |
Use of this online version of BRENDA is free under the CC BY 4.0 license. See terms of use for full details.
Release 2023.1 (January 2023)
Legal
Curated at
Member of
